In this third webinar in our series about the COVID-19 health crisis we tackle some of the latest questions that patients with vasculitis are asking our medical professionals.
Introductions | 0:58 |
Joyce Kullman: The VF Virtual Patient Conference Series | 2:14 |
Webinar Summary | 5:54 |
Have we learned any more about how COVID-19 produces an autoimmune response with inflammation? | 7:19 |
Are there any updates on the status of developing a vaccine? Also, do we know if a vaccine will be safe for patients with vasculitis? | 12:32 |
Can COVID-19 impact the kidney? What does that mean to patients who already have kidney issues? | 17:48 |
Is there any evidence that Vitamin D can help in the prevention or treatment of COVID-19? | 21:18 |
Are there any updates on Remdesivir, or other potential therapeutics for the virus? | 24:57 |
Can you comment on any hypercoagulability issues related to COVID-19? | 31:08 |
Will a vaccine be effective if our blood level B Cells are at zero? | 32:46 |
In this third webinar in our series about the COVID-19 health crisis we tackle some of the latest questions that patients with vasculitis are asking our medical professionals.
Building upon the collective strength of the vasculitis community, the Foundation supports, inspires and empowers individuals with vasculitis and their families through a wide range of education, research, clinical, and awareness initiatives.
The Vasculitis Foundation is a registered 501 (c) (3) non-profit organization. All contributions are 100% tax-deductible.
Click here to send us an email!
Mail:
Vasculitis Foundation
PO Box 28660
Kansas City, MO 64188
1.816.436.8211 or 1.800.277.9474
All Rights Reserved